Assay News and Research

RSS
Study reveals the cross-protective role of Omicron infection in vaccinated individuals

Study reveals the cross-protective role of Omicron infection in vaccinated individuals

Anti-SARS-CoV-2 antibodies persist in breast milk, even after gastrointestinal digestion

Anti-SARS-CoV-2 antibodies persist in breast milk, even after gastrointestinal digestion

ATLAS assay reveals SARS-CoV-2 variant T-cell responses

ATLAS assay reveals SARS-CoV-2 variant T-cell responses

The design of immunogens for the SARS-CoV-2 spike protein using structure-guided epitope grafting and scaffolding methods

The design of immunogens for the SARS-CoV-2 spike protein using structure-guided epitope grafting and scaffolding methods

Study shows a strong negative association between BNT162b2 vaccination-induced S1 IgG concentration and age

Study shows a strong negative association between BNT162b2 vaccination-induced S1 IgG concentration and age

Repurposed drug clofoctol blocks SARS-CoV-2 replication in mouse study

Repurposed drug clofoctol blocks SARS-CoV-2 replication in mouse study

SARS-CoV-2 Omicron subvariants are increasingly escaping immunity

SARS-CoV-2 Omicron subvariants are increasingly escaping immunity

Anti-SARS-CoV-2 titers predict COVID severity

Anti-SARS-CoV-2 titers predict COVID severity

Olverembatinib a potent inhibitor of Omicron NTD-mediated cytokine release

Olverembatinib a potent inhibitor of Omicron NTD-mediated cytokine release

Exploring the possibility of whether surface ACE2 carried by extracellular vesicles can facilitate SARS-CoV-2 infection

Exploring the possibility of whether surface ACE2 carried by extracellular vesicles can facilitate SARS-CoV-2 infection

Important methodology for targeting conserved epitopes of SARS-CoV-2 and an immune-focused approach in pan-sarbeco and universal CoV vaccine design

Important methodology for targeting conserved epitopes of SARS-CoV-2 and an immune-focused approach in pan-sarbeco and universal CoV vaccine design

Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19

Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19

Serologic response to SARS-CoV-2 may predict COVID-19 severity

Serologic response to SARS-CoV-2 may predict COVID-19 severity

L452R mutation a key player in the evolution of SARS-CoV-2

L452R mutation a key player in the evolution of SARS-CoV-2

Mice study links dietary cholesterol with exacerbation of influenza

Mice study links dietary cholesterol with exacerbation of influenza

Downregulation of MHC-I surface expression by SARS-CoV-2 accessory proteins

Downregulation of MHC-I surface expression by SARS-CoV-2 accessory proteins

Micro Products with Macro Impact; The Role of Microplate Readers in Life Sciences

Micro Products with Macro Impact; The Role of Microplate Readers in Life Sciences

The prevalence of rodent-borne zoonotic viruses in Europe among the small mammals inhabiting farming landscapes

The prevalence of rodent-borne zoonotic viruses in Europe among the small mammals inhabiting farming landscapes

Neutralizing antibody responses induced by COVID-19 vaccines against SARS-CoV-2 variants

Neutralizing antibody responses induced by COVID-19 vaccines against SARS-CoV-2 variants

Study investigates the detection of antibodies against SARS-CoV-2 in urine

Study investigates the detection of antibodies against SARS-CoV-2 in urine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.